The chemical giant, looking for a better research climate, joins other German firms in the Western Hemisphere
BASF's decision in 1988 to set up shop in the U.S. is the latest example of an exodus of West German biotechnology companies from their homeland. More recently, Bayer, USA announced that it would open biotechnology labs in West Haven, Conn., and Berkeley, Calif.; and Henkel Corp. chose Santa Rosa, Calif., as its new biotechnology home. Meanwhile, Hoechst AG's nearly completed $38 million biotechnology facility in Frankfurt has sat idle since 1987, while West German politicians and scientists wrangle over rules and regulations to govern the biotechnology industry....
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?